A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder

NCT07747389 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

585

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Lumateperone
DRUG: Placebo

Sponsor

Intra-Cellular Therapies, Inc.